Prevalence of Gastroesophageal Reflux Disease in primary care patients with upper Gastrointestinal symptoms

Study identifier:NIS-GBG-NEX-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A cross-sectional study on the prevalence of GERD in primary care patients with upper GI symptoms using the GERD-Q. The Bulgarian GERD-Q Study

Medical condition

Gastroesophageal Reflux Disease

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

2210

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Nov 2009
Primary Completion Date: 01 Apr 2010
Study Completion Date: 01 Apr 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria